Global Autoimmune Disorder Drug Delivery Device Market Growth 2022-2028
As the global economy mends, the 2021 growth of Autoimmune Disorder Drug Delivery Device will have significant change from previous year. According to our (LP Information) latest study, the global Autoimmune Disorder Drug Delivery Device market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Autoimmune Disorder Drug Delivery Device market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Autoimmune Disorder Drug Delivery Device market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Autoimmune Disorder Drug Delivery Device market, reaching US$ million by the year 2028. As for the Europe Autoimmune Disorder Drug Delivery Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Autoimmune Disorder Drug Delivery Device players cover AbbVie Inc., Amgen Inc., F. Hoffmann- La Roche Ltd., and Novartis AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Autoimmune Disorder Drug Delivery Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Pen Injectors
Auto-Injectors
Prefilled Syringes
Vials
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
In-house Manufacturing
Outsourced Manufacturing
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AbbVie Inc.
Amgen Inc.
F. Hoffmann- La Roche Ltd.
Novartis AG
GlaxoSmithKline Plc
Biogen Inc.
Merck KGaA
Bayer AG
Johnson & Johnson Services Inc.
Teva Pharmaceutical Industries Ltd.
Eli Lily and Company
Sanofi S.A.
Takeda Pharmaceutical Company Limited
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Autoimmune Disorder Drug Delivery Device Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Autoimmune Disorder Drug Delivery Device by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Autoimmune Disorder Drug Delivery Device by Country/Region, 2017, 2022 & 2028
2.2 Autoimmune Disorder Drug Delivery Device Segment by Type
2.2.1 Pen Injectors
2.2.2 Auto-Injectors
2.2.3 Prefilled Syringes
2.2.4 Vials
2.3 Autoimmune Disorder Drug Delivery Device Sales by Type
2.3.1 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2017-2022)
2.3.2 Global Autoimmune Disorder Drug Delivery Device Revenue and Market Share by Type (2017-2022)
2.3.3 Global Autoimmune Disorder Drug Delivery Device Sale Price by Type (2017-2022)
2.4 Autoimmune Disorder Drug Delivery Device Segment by Application
2.4.1 In-house Manufacturing
2.4.2 Outsourced Manufacturing
2.5 Autoimmune Disorder Drug Delivery Device Sales by Application
2.5.1 Global Autoimmune Disorder Drug Delivery Device Sale Market Share by Application (2017-2022)
2.5.2 Global Autoimmune Disorder Drug Delivery Device Revenue and Market Share by Application (2017-2022)
2.5.3 Global Autoimmune Disorder Drug Delivery Device Sale Price by Application (2017-2022)
3 Global Autoimmune Disorder Drug Delivery Device by Company
3.1 Global Autoimmune Disorder Drug Delivery Device Breakdown Data by Company
3.1.1 Global Autoimmune Disorder Drug Delivery Device Annual Sales by Company (2020-2022)
3.1.2 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Company (2020-2022)
3.2 Global Autoimmune Disorder Drug Delivery Device Annual Revenue by Company (2020-2022)
3.2.1 Global Autoimmune Disorder Drug Delivery Device Revenue by Company (2020-2022)
3.2.2 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Company (2020-2022)
3.3 Global Autoimmune Disorder Drug Delivery Device Sale Price by Company
3.4 Key Manufacturers Autoimmune Disorder Drug Delivery Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Autoimmune Disorder Drug Delivery Device Product Location Distribution
3.4.2 Players Autoimmune Disorder Drug Delivery Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Autoimmune Disorder Drug Delivery Device by Geographic Region
4.1 World Historic Autoimmune Disorder Drug Delivery Device Market Size by Geographic Region (2017-2022)
4.1.1 Global Autoimmune Disorder Drug Delivery Device Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Autoimmune Disorder Drug Delivery Device Annual Revenue by Geographic Region
4.2 World Historic Autoimmune Disorder Drug Delivery Device Market Size by Country/Region (2017-2022)
4.2.1 Global Autoimmune Disorder Drug Delivery Device Annual Sales by Country/Region (2017-2022)
4.2.2 Global Autoimmune Disorder Drug Delivery Device Annual Revenue by Country/Region
4.3 Americas Autoimmune Disorder Drug Delivery Device Sales Growth
4.4 APAC Autoimmune Disorder Drug Delivery Device Sales Growth
4.5 Europe Autoimmune Disorder Drug Delivery Device Sales Growth
4.6 Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Growth
5 Americas
5.1 Americas Autoimmune Disorder Drug Delivery Device Sales by Country
5.1.1 Americas Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2022)
5.1.2 Americas Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2022)
5.2 Americas Autoimmune Disorder Drug Delivery Device Sales by Type
5.3 Americas Autoimmune Disorder Drug Delivery Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Autoimmune Disorder Drug Delivery Device Sales by Region
6.1.1 APAC Autoimmune Disorder Drug Delivery Device Sales by Region (2017-2022)
6.1.2 APAC Autoimmune Disorder Drug Delivery Device Revenue by Region (2017-2022)
6.2 APAC Autoimmune Disorder Drug Delivery Device Sales by Type
6.3 APAC Autoimmune Disorder Drug Delivery Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Autoimmune Disorder Drug Delivery Device by Country
7.1.1 Europe Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2022)
7.1.2 Europe Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2022)
7.2 Europe Autoimmune Disorder Drug Delivery Device Sales by Type
7.3 Europe Autoimmune Disorder Drug Delivery Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Autoimmune Disorder Drug Delivery Device by Country
8.1.1 Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2022)
8.1.2 Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2022)
8.2 Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Type
8.3 Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Autoimmune Disorder Drug Delivery Device
10.3 Manufacturing Process Analysis of Autoimmune Disorder Drug Delivery Device
10.4 Industry Chain Structure of Autoimmune Disorder Drug Delivery Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Autoimmune Disorder Drug Delivery Device Distributors
11.3 Autoimmune Disorder Drug Delivery Device Customer
12 World Forecast Review for Autoimmune Disorder Drug Delivery Device by Geographic Region
12.1 Global Autoimmune Disorder Drug Delivery Device Market Size Forecast by Region
12.1.1 Global Autoimmune Disorder Drug Delivery Device Forecast by Region (2023-2028)
12.1.2 Global Autoimmune Disorder Drug Delivery Device Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Autoimmune Disorder Drug Delivery Device Forecast by Type
12.7 Global Autoimmune Disorder Drug Delivery Device Forecast by Application
13 Key Players Analysis
13.1 AbbVie Inc.
13.1.1 AbbVie Inc. Company Information
13.1.2 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Product Offered
13.1.3 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AbbVie Inc. Main Business Overview
13.1.5 AbbVie Inc. Latest Developments
13.2 Amgen Inc.
13.2.1 Amgen Inc. Company Information
13.2.2 Amgen Inc. Autoimmune Disorder Drug Delivery Device Product Offered
13.2.3 Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Amgen Inc. Main Business Overview
13.2.5 Amgen Inc. Latest Developments
13.3 F. Hoffmann- La Roche Ltd.
13.3.1 F. Hoffmann- La Roche Ltd. Company Information
13.3.2 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Product Offered
13.3.3 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 F. Hoffmann- La Roche Ltd. Main Business Overview
13.3.5 F. Hoffmann- La Roche Ltd. Latest Developments
13.4 Novartis AG
13.4.1 Novartis AG Company Information
13.4.2 Novartis AG Autoimmune Disorder Drug Delivery Device Product Offered
13.4.3 Novartis AG Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novartis AG Main Business Overview
13.4.5 Novartis AG Latest Developments
13.5 GlaxoSmithKline Plc
13.5.1 GlaxoSmithKline Plc Company Information
13.5.2 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Product Offered
13.5.3 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GlaxoSmithKline Plc Main Business Overview
13.5.5 GlaxoSmithKline Plc Latest Developments
13.6 Biogen Inc.
13.6.1 Biogen Inc. Company Information
13.6.2 Biogen Inc. Autoimmune Disorder Drug Delivery Device Product Offered
13.6.3 Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Biogen Inc. Main Business Overview
13.6.5 Biogen Inc. Latest Developments
13.7 Merck KGaA
13.7.1 Merck KGaA Company Information
13.7.2 Merck KGaA Autoimmune Disorder Drug Delivery Device Product Offered
13.7.3 Merck KGaA Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merck KGaA Main Business Overview
13.7.5 Merck KGaA Latest Developments
13.8 Bayer AG
13.8.1 Bayer AG Company Information
13.8.2 Bayer AG Autoimmune Disorder Drug Delivery Device Product Offered
13.8.3 Bayer AG Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bayer AG Main Business Overview
13.8.5 Bayer AG Latest Developments
13.9 Johnson & Johnson Services Inc.
13.9.1 Johnson & Johnson Services Inc. Company Information
13.9.2 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Product Offered
13.9.3 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Johnson & Johnson Services Inc. Main Business Overview
13.9.5 Johnson & Johnson Services Inc. Latest Developments
13.10 Teva Pharmaceutical Industries Ltd.
13.10.1 Teva Pharmaceutical Industries Ltd. Company Information
13.10.2 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Product Offered
13.10.3 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.10.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.11 Eli Lily and Company
13.11.1 Eli Lily and Company Company Information
13.11.2 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Product Offered
13.11.3 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Eli Lily and Company Main Business Overview
13.11.5 Eli Lily and Company Latest Developments
13.12 Sanofi S.A.
13.12.1 Sanofi S.A. Company Information
13.12.2 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Product Offered
13.12.3 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Sanofi S.A. Main Business Overview
13.12.5 Sanofi S.A. Latest Developments
13.13 Takeda Pharmaceutical Company Limited
13.13.1 Takeda Pharmaceutical Company Limited Company Information
13.13.2 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Product Offered
13.13.3 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Takeda Pharmaceutical Company Limited Main Business Overview
13.13.5 Takeda Pharmaceutical Company Limited Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Autoimmune Disorder Drug Delivery Device Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Autoimmune Disorder Drug Delivery Device Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Pen Injectors
Table 4. Major Players of Auto-Injectors
Table 5. Major Players of Prefilled Syringes
Table 6. Major Players of Vials
Table 7. Global Autoimmune Disorder Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 8. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 9. Global Autoimmune Disorder Drug Delivery Device Revenue by Type (2017-2022) & ($ million)
Table 10. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Type (2017-2022)
Table 11. Global Autoimmune Disorder Drug Delivery Device Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Autoimmune Disorder Drug Delivery Device Sales by Application (2017-2022) & (K Units)
Table 13. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 14. Global Autoimmune Disorder Drug Delivery Device Revenue by Application (2017-2022)
Table 15. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Application (2017-2022)
Table 16. Global Autoimmune Disorder Drug Delivery Device Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Autoimmune Disorder Drug Delivery Device Sales by Company (2020-2022) & (K Units)
Table 18. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Company (2020-2022)
Table 19. Global Autoimmune Disorder Drug Delivery Device Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Company (2020-2022)
Table 21. Global Autoimmune Disorder Drug Delivery Device Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Autoimmune Disorder Drug Delivery Device Producing Area Distribution and Sales Area
Table 23. Players Autoimmune Disorder Drug Delivery Device Products Offered
Table 24. Autoimmune Disorder Drug Delivery Device Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Autoimmune Disorder Drug Delivery Device Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Autoimmune Disorder Drug Delivery Device Sales Market Share Geographic Region (2017-2022)
Table 29. Global Autoimmune Disorder Drug Delivery Device Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Autoimmune Disorder Drug Delivery Device Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Country/Region (2017-2022)
Table 33. Global Autoimmune Disorder Drug Delivery Device Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2022) & (K Units)
Table 36. Americas Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2017-2022)
Table 37. Americas Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2017-2022)
Table 39. Americas Autoimmune Disorder Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 40. Americas Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 41. Americas Autoimmune Disorder Drug Delivery Device Sales by Application (2017-2022) & (K Units)
Table 42. Americas Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 43. APAC Autoimmune Disorder Drug Delivery Device Sales by Region (2017-2022) & (K Units)
Table 44. APAC Autoimmune Disorder Drug Delivery Device Sales Market Share by Region (2017-2022)
Table 45. APAC Autoimmune Disorder Drug Delivery Device Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Autoimmune Disorder Drug Delivery Device Revenue Market Share by Region (2017-2022)
Table 47. APAC Autoimmune Disorder Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 48. APAC Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 49. APAC Autoimmune Disorder Drug Delivery Device Sales by Application (2017-2022) & (K Units)
Table 50. APAC Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 51. Europe Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2022) & (K Units)
Table 52. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2017-2022)
Table 53. Europe Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2017-2022)
Table 55. Europe Autoimmune Disorder Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 56. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 57. Europe Autoimmune Disorder Drug Delivery Device Sales by Application (2017-2022) & (K Units)
Table 58. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Autoimmune Disorder Drug Delivery Device
Table 68. Key Market Challenges & Risks of Autoimmune Disorder Drug Delivery Device
Table 69. Key Industry Trends of Autoimmune Disorder Drug Delivery Device
Table 70. Autoimmune Disorder Drug Delivery Device Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Autoimmune Disorder Drug Delivery Device Distributors List
Table 73. Autoimmune Disorder Drug Delivery Device Customer List
Table 74. Global Autoimmune Disorder Drug Delivery Device Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Autoimmune Disorder Drug Delivery Device Sales Market Forecast by Region
Table 76. Global Autoimmune Disorder Drug Delivery Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Autoimmune Disorder Drug Delivery Device Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Autoimmune Disorder Drug Delivery Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Autoimmune Disorder Drug Delivery Device Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Autoimmune Disorder Drug Delivery Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Autoimmune Disorder Drug Delivery Device Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Autoimmune Disorder Drug Delivery Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Autoimmune Disorder Drug Delivery Device Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Autoimmune Disorder Drug Delivery Device Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Autoimmune Disorder Drug Delivery Device Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Autoimmune Disorder Drug Delivery Device Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Autoimmune Disorder Drug Delivery Device Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Autoimmune Disorder Drug Delivery Device Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share Forecast by Application (2023-2028)
Table 94. AbbVie Inc. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 95. AbbVie Inc. Autoimmune Disorder Drug Delivery Device Product Offered
Table 96. AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. AbbVie Inc. Main Business
Table 98. AbbVie Inc. Latest Developments
Table 99. Amgen Inc. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 100. Amgen Inc. Autoimmune Disorder Drug Delivery Device Product Offered
Table 101. Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Amgen Inc. Main Business
Table 103. Amgen Inc. Latest Developments
Table 104. F. Hoffmann- La Roche Ltd. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 105. F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Product Offered
Table 106. F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. F. Hoffmann- La Roche Ltd. Main Business
Table 108. F. Hoffmann- La Roche Ltd. Latest Developments
Table 109. Novartis AG Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 110. Novartis AG Autoimmune Disorder Drug Delivery Device Product Offered
Table 111. Novartis AG Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Novartis AG Main Business
Table 113. Novartis AG Latest Developments
Table 114. GlaxoSmithKline Plc Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 115. GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Product Offered
Table 116. GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. GlaxoSmithKline Plc Main Business
Table 118. GlaxoSmithKline Plc Latest Developments
Table 119. Biogen Inc. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 120. Biogen Inc. Autoimmune Disorder Drug Delivery Device Product Offered
Table 121. Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Biogen Inc. Main Business
Table 123. Biogen Inc. Latest Developments
Table 124. Merck KGaA Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 125. Merck KGaA Autoimmune Disorder Drug Delivery Device Product Offered
Table 126. Merck KGaA Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Merck KGaA Main Business
Table 128. Merck KGaA Latest Developments
Table 129. Bayer AG Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 130. Bayer AG Autoimmune Disorder Drug Delivery Device Product Offered
Table 131. Bayer AG Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Bayer AG Main Business
Table 133. Bayer AG Latest Developments
Table 134. Johnson & Johnson Services Inc. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 135. Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Product Offered
Table 136. Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Johnson & Johnson Services Inc. Main Business
Table 138. Johnson & Johnson Services Inc. Latest Developments
Table 139. Teva Pharmaceutical Industries Ltd. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 140. Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Product Offered
Table 141. Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Teva Pharmaceutical Industries Ltd. Main Business
Table 143. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 144. Eli Lily and Company Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 145. Eli Lily and Company Autoimmune Disorder Drug Delivery Device Product Offered
Table 146. Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Eli Lily and Company Main Business
Table 148. Eli Lily and Company Latest Developments
Table 149. Sanofi S.A. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 150. Sanofi S.A. Autoimmune Disorder Drug Delivery Device Product Offered
Table 151. Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. Sanofi S.A. Main Business
Table 153. Sanofi S.A. Latest Developments
Table 154. Takeda Pharmaceutical Company Limited Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors
Table 155. Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Product Offered
Table 156. Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. Takeda Pharmaceutical Company Limited Main Business
Table 158. Takeda Pharmaceutical Company Limited Latest Developments
List of Figures
Figure 1. Picture of Autoimmune Disorder Drug Delivery Device
Figure 2. Autoimmune Disorder Drug Delivery Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Autoimmune Disorder Drug Delivery Device Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Autoimmune Disorder Drug Delivery Device Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Autoimmune Disorder Drug Delivery Device Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Pen Injectors
Figure 10. Product Picture of Auto-Injectors
Figure 11. Product Picture of Prefilled Syringes
Figure 12. Product Picture of Vials
Figure 13. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type in 2021
Figure 14. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Type (2017-2022)
Figure 15. Autoimmune Disorder Drug Delivery Device Consumed in In-house Manufacturing
Figure 16. Global Autoimmune Disorder Drug Delivery Device Market: In-house Manufacturing (2017-2022) & (K Units)
Figure 17. Autoimmune Disorder Drug Delivery Device Consumed in Outsourced Manufacturing
Figure 18. Global Autoimmune Disorder Drug Delivery Device Market: Outsourced Manufacturing (2017-2022) & (K Units)
Figure 19. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2017-2022)
Figure 20. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Application in 2021
Figure 21. Autoimmune Disorder Drug Delivery Device Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Company in 2021
Figure 23. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Geographic Region in 2021
Figure 25. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Region (2017-2022)
Figure 26. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country/Region in 2021
Figure 27. Americas Autoimmune Disorder Drug Delivery Device Sales 2017-2022 (K Units)
Figure 28. Americas Autoimmune Disorder Drug Delivery Device Revenue 2017-2022 ($ Millions)
Figure 29. APAC Autoimmune Disorder Drug Delivery Device Sales 2017-2022 (K Units)
Figure 30. APAC Autoimmune Disorder Drug Delivery Device Revenue 2017-2022 ($ Millions)
Figure 31. Europe Autoimmune Disorder Drug Delivery Device Sales 2017-2022 (K Units)
Figure 32. Europe Autoimmune Disorder Drug Delivery Device Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue 2017-2022 ($ Millions)
Figure 35. Americas Autoimmune Disorder Drug Delivery Device Sales Market Share by Country in 2021
Figure 36. Americas Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country in 2021
Figure 37. United States Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Autoimmune Disorder Drug Delivery Device Sales Market Share by Region in 2021
Figure 42. APAC Autoimmune Disorder Drug Delivery Device Revenue Market Share by Regions in 2021
Figure 43. China Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Country in 2021
Figure 50. Europe Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country in 2021
Figure 51. Germany Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country in 2021
Figure 58. Egypt Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Autoimmune Disorder Drug Delivery Device in 2021
Figure 64. Manufacturing Process Analysis of Autoimmune Disorder Drug Delivery Device
Figure 65. Industry Chain Structure of Autoimmune Disorder Drug Delivery Device
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets